Wilms’ tumor gene 1 (WT1) is highly expressed in most acute leukemia patients and can be quantitatively detected, enabling it to be a potential MRD marker for pediatric AML without special molecular markers [7]. Here, WT1 is linked to acute myeloid leukemia.